FOCUS UNIVERSAL INC. (FCUV) Spending and interest coverage
- R&D / revenue · 12 months: Value 93.99%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 93.99% | Research and development expense / revenue. Period ending 2026-06-30. $707.37K ÷ $752.58K × 100 ≈ 93.99% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 707.37K USD | Research and Development Expense |
| Revenue | 752.58K USD | |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -4.90M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $707.37K | $752.58K | (m) | $-4.90M | (m) | 93.99% | (m) | (m) | (m) |
| 2026-03-31 | $812.50K | $112.74K | (m) | $-4.89M | (m) | 720.68% | (m) | (m) | (m) |
| 2025-12-31 | $919.97K | $255.02K | (m) | $-4.89M | (m) | 360.74% | (m) | (m) | (m) |
| 2025-09-30 | $1.56M | $387.46K | (m) | $-6.00M | (m) | 403.02% | (m) | (m) | (m) |
| 2025-06-30 | $1.58M | $432.98K | (m) | $-6.57M | (m) | 365.36% | (m) | (m) | (m) |
| 2025-03-31 | $1.41M | $408.89K | (m) | $-6.26M | (m) | 345.06% | (m) | (m) | (m) |
| 2024-12-31 | $1.38M | $398.14K | (m) | $-6.20M | (m) | 347.10% | (m) | (m) | (m) |
| 2024-09-30 | $1.41M | $1.08M | (m) | $-5.71M | (m) | 130.71% | (m) | (m) | (m) |
| 2024-06-30 | $1.41M | $839.62K | (m) | $-5.35M | (m) | 167.56% | (m) | (m) | (m) |
| 2024-03-31 | $1.45M | $1.04M | (m) | $-5.04M | (m) | 140.41% | (m) | (m) | (m) |
| 2023-12-31 | $1.39M | $1.05M | (m) | $-4.96M | (m) | 131.80% | (m) | (m) | (m) |
| 2023-09-30 | $1.12M | $841.01K | (m) | $-4.45M | (m) | 133.59% | (m) | (m) | (m) |
| 2023-06-30 | $950.75K | $583.30K | (m) | $-4.39M | (m) | 163.00% | (m) | (m) | (m) |
| 2023-03-31 | $775.12K | $432.55K | $-8.00K | $-4.52M | (m) | 179.20% | -1.85% | (m) | (m) |
| 2022-12-31 | $1.06M | $353.62K | $0.00 | $-5.21M | (m) | 299.87% | 0.00% | (m) | (m) |
| 2022-09-30 | $916.79K | $456.99K | $12.00K | $-4.98M | (m) | 200.61% | 2.63% | (m) | (m) |
| 2022-06-30 | $839.20K | $1.03M | $24.00K | $-4.76M | (m) | 81.39% | 2.33% | (m) | (m) |
| 2022-03-31 | $719.06K | $1.23M | $44.00K | $-4.22M | (m) | 58.55% | 3.58% | (m) | (m) |
| 2021-12-31 | $220.47K | $1.43M | $48.00K | $-3.02M | (m) | 15.37% | 3.35% | (m) | (m) |
| 2021-09-30 | $228.30K | $1.65M | $48.00K | $-2.74M | (m) | 13.84% | 2.91% | (m) | (m) |
| 2021-06-30 | $234.81K | $1.56M | $48.00K | $-2.46M | (m) | 15.06% | 3.08% | (m) | (m) |
| 2021-03-31 | $249.39K | $1.73M | $48.00K | $-2.45M | (m) | 14.40% | 2.77% | (m) | (m) |
| 2020-12-31 | $256.64K | $1.68M | $48.00K | $-2.70M | (m) | 15.29% | 2.86% | (m) | (m) |
| 2020-09-30 | $256.45K | $1.64M | $51.25K | $-3.52M | (m) | 15.66% | 3.13% | (m) | (m) |
| 2020-06-30 | $260.70K | $1.53M | $51.22K | $-4.00M | (m) | 17.00% | 3.34% | (m) | (m) |
| 2020-03-31 | $263.62K | $1.62M | $51.22K | $-3.76M | (m) | 16.30% | 3.17% | (m) | (m) |
| 2019-12-31 | $255.23K | $1.46M | $75.22K | $-3.33M | (m) | 17.48% | 5.15% | (m) | (m) |
| 2019-09-30 | $247.79K | $1.06M | $131.96K | $-3.06M | (m) | 23.47% | 12.50% | (m) | (m) |
| 2019-06-30 | $240.44K | $862.87K | $132.00K | $-1.67M | (m) | 27.87% | 15.30% | (m) | (m) |
| 2019-03-31 | $232.50K | $482.31K | $577.38K | $-1.88M | (m) | 48.20% | 119.71% | (m) | (m) |
| 2018-12-31 | $221.51K | $308.13K | $541.38K | $-1.58M | (m) | 71.89% | 175.70% | (m) | (m) |
| 2018-09-30 | $197.17K | $297.65K | (m) | $-1.40M | (m) | 66.24% | (m) | (m) | (m) |
| 2018-06-30 | $206.10K | $108.33K | (m) | $-1.16M | (m) | 190.25% | (m) | (m) | (m) |
| 2018-03-31 | $204.78K | $697.18K | (m) | $-556.04K | (m) | 29.37% | (m) | (m) | (m) |
| 2017-12-31 | $208.24K | $898.08K | (m) | $-519.84K | (m) | 23.19% | (m) | (m) | (m) |
| 2017-09-30 | $234.11K | $286.64K | (m) | $-446.61K | (m) | 81.67% | (m) | (m) | (m) |
| 2017-06-30 | $228.85K | $377.59K | (m) | $-450.44K | (m) | 60.61% | (m) | (m) | (m) |
| 2017-03-31 | $219.84K | $335.30K | (m) | $-442.39K | (m) | 65.57% | (m) | (m) | (m) |
| 2016-12-31 | $201.90K | $337.50K | $0.00 | $-443.24K | $203.00 | 59.82% | 0.00% | -2183.43× | Reported |
| 2016-09-30 | (m) | $256.87K | $0.00 | $-358.47K | (m) | (m) | 0.00% | (m) | (m) |
| 2016-06-30 | (m) | $186.83K | $0.00 | $-290.19K | (m) | (m) | 0.00% | (m) | (m) |
| 2016-03-31 | (m) | $102.23K | (m) | $-229.25K | $4.31K | (m) | (m) | -53.14× | Reported |
| 2015-12-31 | (m) | $17.85K | (m) | $-140.47K | $3.92K | (m) | (m) | -35.85× | Reported |
| 2015-09-30 | (m) | $11.64K | (m) | $-108.78K | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $15.46K | (m) | $-97.51K | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $20.15K | (m) | $-84.34K | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $24.18K | (m) | $-63.68K | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $28.55K | (m) | $-55.99K | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $22.60K | (m) | $-42.04K | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $15.90K | (m) | $-20.51K | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ClearSign Technologies Corp (CLIR) | United States | $0.024B | -4.54 |
| SYPRIS SOLUTIONS INC (SYPR) | United States | $0.040B | -4.94 |
| HURCO COMPANIES INC (HURC) | United States | $0.140B | -20.39 |
| Senseonics Holdings, Inc. (SENS) | United States | $0.546B | -2.74 |
| MESA LABORATORIES INC /CO/ (MLAB) | United States | $0.768B | 116.22 |
| Sensata Technologies Holding plc (ST) | $5.976B | 77.15 | |
| Ralliant Corp (RAL) | United States | $7.737B | -6.14 |
| COGNEX CORP (CGNX) | United States | $9.711B | 65.26 |
| Fortive Corp (FTV) | United States | $16.897B | 31.51 |
| MKS INC (MKSI) | United States | $17.440B | 68.37 |